NewsAlphagreen To Raise £2m Growth Funding At A Valuation...

Alphagreen To Raise £2m Growth Funding At A Valuation Of £10m

-

FAST-growing UK CBD, health and medical cannabis business the Alphagreen Group has launched £2m funding round with half of the fund-raise set to come from the Seedrs investment platform.

Alphagreen’s growth has been rapid with its initial B2C CBD marketplace now hosting over 150 brands as it expands its presence across Europe and into Asia.

It also recently launched the Nuoptima B2B platform featuring SEO ranking, social influencer, AdWords, email marketing, and cross-border distribution, with others, set to follow.

CEO & Co-Founder of Alexej Pikovsky said it is raising the cash based on a valuation of £10m with the £2m to be used used across its business streams.

He said: “The funds will be used to boost our international growth, continue our work with the best global brands, roll-out our business intelligence and growth platform and enter the medical cannabis space.”

Alphagreen CBD

Mr Pikovsky said Alphagreen had been contemplating a number of fund-raising avenues before settling on a private fund-raise, alongside Seedrs.

He said: “It’s a nice alternative to the public markets as you can also trade your investments on the Seedrs Secondary Market and it will allow us to continue to build our business in a long-term, sustainable way.”

The London-based Seedrs platform has some 500,000 active investors and taps into the emerging appetite for individual investment amongst a younger demographic.

Alphagreen.io is one of Europe’s leading CBD marketplaces and currently hosts 2,500 products and 150-plus brands. It has a presence in Germany and Sweden, Spain, Italy and France and Poland, with Hong Kong and Japan set to follow.

Writing on LinkedIn Mr Pikovsky said: “We’re crowdfunding one of the biggest rounds in the health space this year! Become an investor in Alphagreen and be part of the revolution.”

The Alphagreen Group also operates a German subsidiary for the import and distribution of medical cannabis.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Tilray’s Medical Cannabis Product Now Available And Reimbursed Under Ireland’s Medical Cannabis Access Program

PRESS RELEASE TILRAY Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and...

Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses

AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies...

MGC Pharma Announces Appointment Of UK Advisor And New COO/Deputy CEO

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based bio-pharma company specialising in the production and development...

Sanity Group’s Record Funding Round Led By BAT Could Bring More Big-Tobacco Capital To Cannabis, But Concerns Remain Over Conflicts Of Interest

LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total...

European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos

FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE),...

German SPD Representatives Confident A Solution To International Legal Hurdles Will Be Found

EARLIER this month news broke that recent analysis conducted by the Bundestag's scientific service suggested the creation of a...

Must read

You might also likeRELATED
Recommended to you